|
|
Article: Geron to Present at 4 Upcoming Investor Conferences.(Conference news)
- Article from:
- Health & Beauty Close-Up
- Article date:
- September 1, 2009
CopyrightCOPYRIGHT 2009 Close-Up Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Geron Corp. announced that the company will present updates of its product development programs at four investor conferences in the month of September.
In a release, the Company noted event details:
Stephen M. Kelsey, M.D., F.R.C.P., F.R.C.Path., executive vice president and chief medical officer for oncology, will review Geron's portfolio of anti-cancer therapies, including its telomerase inhibitor drug (imetelstat - GRN163L) and its telomerase therapeutic vaccine (GRNVAC1) at the following conference:
- Rodman & Renshaw 11th Annual Healthcare Conference in New York, at 9:35 am ET on Thursday, September 10.
Thomas B. Okarma, Ph.D., ...